DIA, a global non-profit organization of life sciences professionals, will unite stakeholders from across Europe and the world to discuss increasing efficiencies in healthcare systems, the future of international collaboration, and recent changes to regulatory frameworks at DIA Europe 2025 from March 18-20 in Basel. The continent's premier neutral healthcare conference, DIA Europe 2025 will host more than 300 speakers from over 150 organizations and present over 100 topics across 10 content tr...

Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today announced that its Affirm® Contrast Biopsy Software, which combines contrast-enhanced diagnostic capabilities with accurate lesion targeting to help streamline workflow and accelerate biopsy procedures,1-2 is now CE-marked. The technology received clearance from the U.S. Food and Drug Administration in October 2020. Designed from the ground up to integrate with the Selenia® Dimensions® and 3Dimensions™ systems, Hologic’s Affirm Co...

Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 million cells and 384 samples in a single run. Evercode Penta and Penta 384 will begin shipping to customers the week of March 17. Scaling up single cell experiments—processing millions of cells instead of thousands—has revolutionized the way researchers study development, disease, and cellular heterogene...